Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-02 Tax Withholding |
2021-11-03 4:16 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
62 | $1.98 | 15,136 (Direct) |
View |
| 2021-10-04 Tax Withholding |
2021-10-05 6:40 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
62 | $2.01 | 15,198 (Direct) |
View |
| 2021-09-02 Tax Withholding |
2021-09-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
61 | $1.81 | 15,260 (Direct) |
View |
| 2021-08-03 Tax Withholding |
2021-08-04 5:45 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
63 | $2.4 | 15,321 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
154 | $3.7 | 15,384 (Direct) |
View |
| 2021-06-04 Tax Withholding |
2021-06-07 5:01 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
155 | $4.19 | 15,538 (Direct) |
View |
| 2021-05-04 Tax Withholding |
2021-05-05 9:56 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
191 | $4.13 | 15,693 (Direct) |
View |
| 2021-04-08 Tax Withholding |
2021-04-09 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
192 | $4.94 | 15,884 (Direct) |
View |
| 2021-03-03 Tax Withholding |
2021-03-05 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
192 | $5.46 | 16,076 (Direct) |
View |
| 2021-02-02 Tax Withholding |
2021-02-03 9:53 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
988 | $6.34 | 26,268 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:53 pm |
N/A 2031-02-01 |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
10,000 | $0 | 26,268 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-05 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
115 | $4.85 | 17,256 (Direct) |
View |
| 2020-12-07 Tax Withholding |
2020-12-08 8:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
91 | $3.76 | 17,371 (Direct) |
View |
| 2020-11-02 Tax Withholding |
2020-11-03 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
96 | $3.51 | 17,462 (Direct) |
View |
| 2020-10-02 Tax Withholding |
2020-10-05 5:56 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
98 | $3.88 | 17,558 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 5:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
97 | $3.94 | 17,656 (Direct) |
View |
| 2020-08-04 Tax Withholding |
2020-08-05 5:11 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
92 | $4.11 | 17,753 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-06 4:15 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
94 | $4.82 | 17,845 (Direct) |
View |
| 2020-06-03 Tax Withholding |
2020-06-04 4:17 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
94 | $5.11 | 17,939 (Direct) |
View |
| 2020-05-05 Tax Withholding |
2020-05-06 4:31 pm |
N/A N/A |
EYEGATE PHARMACEUTICALS INC | EYEG | Mann Brenda VP of Research & Development |
113 | $5.1 | 18,033 (Direct) |
View |